Date published: 2026-6-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

CTGF Inhibitors

Connective Tissue Growth Factor (CTGF) Inhibitors belong to a distinctive category of molecules that primarily target the signaling pathway involving CTGF. This pathway is intricately involved in various physiological processes, chiefly those related to tissue repair and remodeling. CTGF, a secreted protein, plays a pivotal role in modulating cellular events like proliferation, migration, and differentiation, especially in the context of connective tissues. CTGF Inhibitors are designed to impede the activity of CTGF, thus interfering with the downstream effects it mediates. These inhibitors operate through a range of mechanisms, including direct binding to CTGF, interference with its interaction partners, or hindrance of downstream signal transduction pathways activated by CTGF. By efficiently blocking the activity of CTGF, these inhibitors possess the ability to influence cellular responses associated with tissue maintenance and remodeling, although their specific applications are beyond the scope of this discussion. Structurally, CTGF Inhibitors can encompass a diverse array of chemical entities, each designed to engage with the CTGF signaling pathway in distinct ways. These inhibitors can be synthesized using various chemical methodologies, resulting in a broad spectrum of molecular architectures. Researchers often aim to enhance the selectivity and potency of these inhibitors, tailoring their properties to achieve the desired effects on CTGF-mediated cellular events. Due to the fundamental role of CTGF in various cellular processes, CTGF Inhibitors have garnered considerable attention in scientific investigations. Their implications extend to numerous fields that involve tissue biology, but it is important to note that their precise applications remain outside the scope of this explanation. In summary, CTGF Inhibitors represent a class of compounds strategically designed to modulate CTGF-related cellular activities, with their diverse chemical structures and mechanisms of action offering promising avenues for further research and applications in various biological contexts.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Pirfenidone

53179-13-8sc-203663
sc-203663A
10 mg
50 mg
$102.00
$416.00
6
(1)

Pirfenidone is an anti-fibrotic agent that targets CTGF by inhibiting TGF-β signaling pathways, reducing collagen synthesis, and suppressing fibroblast proliferation, thereby mitigating fibrosis progression in various organs.

LY2157299

700874-72-2sc-391123
sc-391123A
5 mg
10 mg
$213.00
$359.00
3
(1)

LY2157299 is a selective TGF-β receptor type 1 inhibitor that impedes CTGF expression by disrupting TGF-β signaling. This inhibition hampers fibrosis development in tissues and organs affected by excessive collagen deposition.

AS 101

106566-58-9sc-203825
sc-203825A
10 mg
25 mg
$163.00
$587.00
4
(2)

AS-101 has anti-fibrotic properties by modulating TGF-β/CTGF signaling pathways. It reduces fibrotic processes by affecting collagen production and deposition, which is crucial in managing fibrotic diseases.